Aisha Alyassi et al. 2024. GLP-1 RECEPTOR AGONISTS AS A BREAKTHROUGH THERAPY FOR OBESITY AND METABOLIC SYNDROME: A SYSTEMATIC REVIEW OF EFFICACY AND LONG-TERM OUTCOMES. Journal of Population Therapeutics and Clinical Pharmacology. 31, 11 (Dec. 2024), 1915–1925. DOI:https://doi.org/10.53555/6tdd8g65.